ipriflavone has been researched along with Amyloidosis in 1 studies
ipriflavone : A member of the class of isoflavones that is isoflavone in which the hydrogen at position 7 is replaced by an isopropoxy group. A synthetic isoflavone, it was formerly used for the treatment of osteoporosis, although a randomised controlled study failed to show any benefit. It is still used to prevent osteoporosis in post-menopausal women.
Amyloidosis: A group of sporadic, familial and/or inherited, degenerative, and infectious disease processes, linked by the common theme of abnormal protein folding and deposition of AMYLOID. As the amyloid deposits enlarge they displace normal tissue structures, causing disruption of function. Various signs and symptoms depend on the location and size of the deposits.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Enhanced bone resorption was also observed when unfractionated bone cells were cultured on AGE-modified dentin slices." | 1.30 | Advanced glycation end products enhance osteoclast-induced bone resorption in cultured mouse unfractionated bone cells and in rats implanted subcutaneously with devitalized bone particles. ( Horie, K; Kurokawa, K; Maeda, K; Miyata, T; Notoya, K; Taketomi, S; Yoshida, K, 1997) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Miyata, T | 1 |
| Notoya, K | 1 |
| Yoshida, K | 1 |
| Horie, K | 1 |
| Maeda, K | 1 |
| Kurokawa, K | 1 |
| Taketomi, S | 1 |
1 other study available for ipriflavone and Amyloidosis
| Article | Year |
|---|---|
Advanced glycation end products enhance osteoclast-induced bone resorption in cultured mouse unfractionated bone cells and in rats implanted subcutaneously with devitalized bone particles.
Topics: Amyloidosis; Animals; beta 2-Microglobulin; Bone Resorption; Bone Transplantation; Calcitonin; Cells | 1997 |